Zai Lab Ltd 9688-HK:Hong Kong Stock Exchange

*Data is delayed | HKD
Last | 4:08 PM CTT
33.65quote price arrow down-0.60 (-1.75%)
Volume
381,100
52 week range
17.60 - 118.00
Loading...
  • Open34.30
  • Day High34.50
  • Day Low33.45
  • Prev Close34.25
  • 52 Week High118.00
  • 52 Week High Date09/08/21
  • 52 Week Low17.60
  • 52 Week Low Date06/17/22

Key Stats

  • Market Cap4,347.22M
  • Shares Out958.49M
  • 10 Day Average Volume589,673.45
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-33.5

KEY STATS

  • Open34.30
  • Day High34.50
  • Day Low33.45
  • Prev Close34.25
  • 52 Week High118.00
  • 52 Week High Date09/08/21
  • 52 Week Low17.60
  • 52 Week Low Date06/17/22
  • Market Cap4,347.22M
  • Shares Out958.49M
  • 10 Day Average Volume589,673.45
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-33.5

RATIOS/PROFITABILITY

  • EPS (TTM)-4.34
  • P/E (TTM)-7.75
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Zai Lab Ltd

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Zai Lab Ltd is a holding company mainly engaged in the biopharmaceutical field. The Company is focused on discovering or licensing, developing and commercializing proprietary therapeutics that address areas of large unmet medical need in the China market, including oncology, autoimmune and infectious diseases fields. The Company has a broad pipeline of proprietary drug candidates that range from discovery stage to late-stage clinical programs. These include Niraparib...
Du Ying Ph.D.
Chairman of the Board, Chief Executive Officer, Co-Founder
Joshua Smiley
Chief Operating Officer
Billy Cho
Chief Financial Officer
Address
4560 Jinke Road, Bldg. 1, 4/F, Pudong
Shanghai, SHA
201210
China